Clinical Trial

Contrast-Free Magnetic Resonance Imaging for Breast Disease

Study acronym: IMOGEN
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, observational cohort study looking at patients either at risk of breast cancer or have clinically suspected breast to assess the diagnostic performance of quantitative, non-contrast MRI.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-08-06; most recent amendment 2026-05-19.
Status change: Recruiting → Active, Not Recruiting 2025-11-27
Trial Details
NCT Number NCT05006196
Lead Sponsor Perspectum
Conditions Breast Cancer, Breast Diseases
Enrollment 1,030 participants
Start Date 2021-07-06
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-20